Dan Siegwart, Ph.D., utilized a materials chemistry approach to engineer nanoparticles capable of delivering RNAs, proteins, and gene editors deep into targeted organs and tumors. His work has advanced the understanding of the critical physical and chemical properties required for the effective therapeutic delivery of biomolecule-based medicines to specific organs impacted by disease. His innovations have also led to more than 300 issued and pending patents worldwide.